Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Status: Publicly traded
Direct answer
Jiangsu Hengrui Pharmaceuticals Co.,Ltd is publicly traded on HKSE under the ticker 1276.HK.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune...
Can you invest in Jiangsu Hengrui Pharmaceuticals Co.,Ltd?
Yes. Jiangsu Hengrui Pharmaceuticals Co.,Ltd trades publicly on HKSE as 1276.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Detailed equity research is provided by MarketSnap.